Open AccessMutational analysis of T315I in patients with chronic myeloid leukemia who did not respond to second-generation tyrosine kinase inhibitors
Author(s) -
RiyamQusay Ibrahim Al-Jadir,
JaffarNouri Alalsaidissa
Publication year - 2020
Publication title -
iraqi journal of hematology
Language(s) - English
Resource type - Journals
eISSN - 2543-2702
pISSN - 2072-8069
DOI - 10.4103/ijh.ijh_31_20
Subject(s) - medicine , chronic myelogenous leukemia , mutation , sanger sequencing , tyrosine kinase , myeloid leukemia , tyrosine kinase inhibitor , nilotinib , dasatinib , point mutation , oncology , leukemia , immunology , cancer research , imatinib , gene , genetics , biology , cancer , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom